TradingKey - UnitedHealth beat Q2 2026 EPS by 30%, reported an 86.7% medical cost ratio (down from 89.4%), and raised full-year guidance to $19.50 to $20.00 per share. At $425 in a rising channel, here’s what $454 needs and why the DOJ investigation still matters.

TradingKeyFri, Jul 17

Eli Lilly Zepbound Returns to CVS Formulary, Pre-Market Shares Rise as Much as 2%

TradingKey - Eli Lilly (LLY) shares rose nearly 2% in Thursday’s pre-market session as the market focused on a major decision from U.S. healthcare giant CVS Health (CVS). CVS announced it would restore insurance coverage for the weight-loss drug Zepbound and include Foundayo, an oral weight-loss medication newly approved in April, in its standard drug formulary.

TradingKeyThu, May 28

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

TradingKeyWed, May 13

Hims & Hers (HIMS) Q1 2026 Earnings Preview: GLP-1 Pivot, Subscriber Surge & Stock Catalyst Watch

TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

TradingKeyTue, May 12

Blue Cross Blue Shield Pays $2.67 Billion Settlement, Why ELV Stock Price Wasn’t Dragged Down?

TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

TradingKeyThu, May 7

UnitedHealth Beats Q1 2026 and Raises Guidance - Is UNH Stock a Buy After Jumping 8%?

UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?

TradingKeyWed, Apr 22